1. Philpott H, Nandurkar S, Thien F, Gibson PR, Royce SG. 2015; Eosinophilic esophagitis: a clinicopathological review. Pharmacol Ther. 146:12–22. DOI:
10.1016/j.pharmthera.2014.09.001. PMID:
25200122.
2. Cheng E, Souza RF, Spechler SJ. 2012; Tissue remodeling in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol. 303:G1175–G1187. DOI:
10.1152/ajpgi.00313.2012. PMID:
23019192. PMCID:
PMC3532456.
3. Liacouras CA, Furuta GT, Hirano I, et al. 2011; Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 128:3–20.e6. quiz 21–22. DOI:
10.1016/j.jaci.2011.04.016. PMID:
21477849.
4. Furuta GT, Liacouras CA, Collins MH, et al. 2007; Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 133:1342–1363. DOI:
10.1053/j.gastro.2007.08.017. PMID:
17919504.
5. Prasad GA, Talley NJ, Romero Y, et al. 2007; Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 102:2627–2632. DOI:
10.1111/j.1572-0241.2007.01512.x. PMID:
17764492.
6. Schoepfer AM, Safroneeva E, Bussmann C, et al. 2013; Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 145:1230–1236.e1-2. DOI:
10.1053/j.gastro.2013.08.015. PMID:
23954315.
7. Dellon ES, Khoury P, Muir AB, et al. 2022; A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions. J Allergy Clin Immunol. 150:33–47. DOI:
10.1016/j.jaci.2022.03.015. PMID:
35606166. PMCID:
PMC9549868.
10. Croese J, Fairley SK, Masson JW, et al. 2003; Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 58:516–522. DOI:
10.1067/S0016-5107(03)01870-4. PMID:
14520283.
11. Prasad GA, Talley NJ, Romero Y, et al. 2007; Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 102:2627–2632. DOI:
10.1111/j.1572-0241.2007.01512.x. PMID:
17764492.
12. Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. 2013; ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 108:679–692. quiz 693DOI:
10.1038/ajg.2013.71. PMID:
23567357.
13. Kagalwalla AF, Sentongo TA, Ritz S, et al. 2006; Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 4:1097–1102. DOI:
10.1016/j.cgh.2006.05.026. PMID:
16860614.
14. Dellon ES, Woosley JT, Arrington A, et al. 2019; Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial. Gastroenterology. 157:65–73.e5. DOI:
10.1053/j.gastro.2019.03.014. PMID:
30872104. PMCID:
PMC6581596.
15. Kim GH, Park YS, Jung KW, et al. 2019; An increasing trend of eosinophilic esophagitis in Korea and the clinical implication of the biomarkers to determine disease activity and treatment response in eosinophilic esophagitis. J Neurogastroenterol Motil. 25:525–533. DOI:
10.5056/jnm19066. PMID:
31587544. PMCID:
PMC6786448.
16. Kim SJ, Park MI, Kim GH, et al. 2021; Practice patterns for eosinophilic esophagitis patients in Busan and Gyeongnam: A Korean multicenter database study. J Neurogastroenterol Motil. 27:71–77. DOI:
10.5056/jnm20069. PMID:
32699187. PMCID:
PMC7786091.